BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31532776)

  • 1. Gene dysregulation in peripheral blood of moyamoya disease and comparison with other vascular disorders.
    Peng X; Zhang Z; Ye D; Xing P; Zou Z; Lei H; Duan L
    PLoS One; 2019; 14(9):e0221811. PubMed ID: 31532776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular Smooth Muscle Cell Derived from IPS Cell of Moyamoya Disease - Comparative Characterization with Endothelial Cell Transcriptome.
    Tokairin K; Hamauchi S; Ito M; Kazumata K; Sugiyama T; Nakayama N; Kawabori M; Osanai T; Houkin K
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105305. PubMed ID: 32992193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of immune-infiltrated hub genes as potential biomarkers of Moyamoya disease by bioinformatics analysis.
    Jin F; Duan C
    Orphanet J Rare Dis; 2022 Feb; 17(1):80. PubMed ID: 35197088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA-mRNA Co-expression Profiles Relative to Vascular Remodeling in Moyamoya Patients Without RNF213 Mutation.
    Zhao J; Qiu C; Zhang G; Chen L; He S; Ma J
    World Neurosurg; 2022 Feb; 158():e880-e888. PubMed ID: 34848385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA profiling of neutrophil transcriptome provides insights into asymptomatic Moyamoya disease.
    Ma Q; Li L; Yu B; Jiao L; Han Z; Zhao H; Li G; Ma Y; Luo Y
    Brain Res; 2019 Sep; 1719():104-112. PubMed ID: 31132337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Analysis of LncRNA-mRNA Co-Expression Profiles in Patients with Moyamoya Disease.
    Wang W; Gao F; Zhao Z; Wang H; Zhang L; Zhang D; Zhang Y; Lan Q; Wang J; Zhao J
    Sci Rep; 2017 Feb; 7():42421. PubMed ID: 28176861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of PANoptosis-related genes and the immune landscape in moyamoya disease.
    Zhou Z; Wang Y; Zhang J; Liu Z; Hao X; Wang X; He S; Wang R
    Sci Rep; 2024 May; 14(1):10278. PubMed ID: 38704490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Noncoding RNAs and Their Regulatory Network: Potential Therapeutic Targets for Adult Moyamoya Disease.
    Gao F; Yu L; Zhang D; Zhang Y; Wang R; Zhao J
    World Neurosurg; 2016 Sep; 93():111-9. PubMed ID: 27268316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smooth-muscle progenitor cells isolated from patients with moyamoya disease: novel experimental cell model.
    Kang HS; Moon YJ; Kim YY; Park WY; Park AK; Wang KC; Kim JE; Phi JH; Lee JY; Kim SK
    J Neurosurg; 2014 Feb; 120(2):415-25. PubMed ID: 24160477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic Profiling of Exosomes From Hemorrhagic Moyamoya Disease and Dysfunction of Mitochondria in Endothelial Cells.
    Wang X; Han C; Jia Y; Wang J; Ge W; Duan L
    Stroke; 2021 Oct; 52(10):3351-3361. PubMed ID: 34334053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomic Profiling of Intracranial Arteries in Adult Patients With Moyamoya Disease Reveals Novel Insights Into Its Pathogenesis.
    Xu S; Wei W; Zhang F; Chen T; Dong L; Shi J; Wu X; Zhang T; Li Z; Zhang J; Li X; Chen J
    Front Mol Neurosci; 2022; 15():881954. PubMed ID: 35711733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Adjustments by LncRNAs in Peripheral Neutrophils Partly Account for the Complete Compensation of Asymptomatic MMD Patients.
    Han Z; Li L; Liu P; Huang Y; Zhang S; Li G; Li F; Zhao H; Tao Z; Wang R; Ma Q; Luo Y
    CNS Neurol Disord Drug Targets; 2020; 19(4):306-317. PubMed ID: 32552656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network-based gene expression analysis of vascular wall of juvenile Moyamoya disease.
    Okami N; Aihara Y; Akagawa H; Yamaguchi K; Kawashima A; Yamamoto T; Okada Y
    Childs Nerv Syst; 2015 Mar; 31(3):399-404. PubMed ID: 25503250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune cell landscape and T-cell abnormalities in patients with moyamoya disease.
    Ge P; Tao C; Wang W; He Q; Liu C; Zheng Z; Mou S; Zhang B; Liu X; Zhang Q; Wang R; Li H; Zhang D; Zhao J
    Clin Transl Med; 2024 Apr; 14(4):e1647. PubMed ID: 38566524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins and endothelial microRNA expression analysis using iPS cell line.
    Uchino H; Ito M; Kazumata K; Hama Y; Hamauchi S; Terasaka S; Sasaki H; Houkin K
    BMC Med Genomics; 2018 Aug; 11(1):72. PubMed ID: 30157848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome-wide analysis of intracranial artery in patients with moyamoya disease showing upregulation of immune response, and downregulation of oxidative phosphorylation and DNA repair.
    Kanamori F; Yokoyama K; Ota A; Yoshikawa K; Karnan S; Maruwaka M; Shimizu K; Ota S; Uda K; Araki Y; Okamoto S; Maesawa S; Wakabayashi T; Natsume A
    Neurosurg Focus; 2021 Sep; 51(3):E3. PubMed ID: 34469870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA profile of the intracranial artery in patients with moyamoya disease.
    Mamiya T; Kanamori F; Yokoyama K; Ota A; Karnan S; Uda K; Araki Y; Maesawa S; Yoshikawa K; Saito R
    J Neurosurg; 2023 Mar; 138(3):709-716. PubMed ID: 35907193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of circular RNAs in Moyamoya disease.
    Zhao M; Gao F; Zhang D; Wang S; Zhang Y; Wang R; Zhao J
    J Neurol Sci; 2017 Oct; 381():25-31. PubMed ID: 28991692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DIAPH1 Variants in Non-East Asian Patients With Sporadic Moyamoya Disease.
    Kundishora AJ; Peters ST; Pinard A; Duran D; Panchagnula S; Barak T; Miyagishima DF; Dong W; Smith H; Ocken J; Dunbar A; Nelson-Williams C; Haider S; Walker RL; Li B; Zhao H; Thumkeo D; Marlier A; Duy PQ; Diab NS; Reeves BC; Robert SM; Sujijantarat N; Stratman AN; Chen YH; Zhao S; Roszko I; Lu Q; Zhang B; Mane S; Castaldi C; López-Giráldez F; Knight JR; Bamshad MJ; Nickerson DA; Geschwind DH; Chen SL; Storm PB; Diluna ML; Matouk CC; Orbach DB; Alper SL; Smith ER; Lifton RP; Gunel M; Milewicz DM; Jin SC; Kahle KT
    JAMA Neurol; 2021 Aug; 78(8):993-1003. PubMed ID: 34125151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA profiling of sEV (small extracellular vesicles)/exosomes reveals biomarkers and vascular endothelial dysplasia with moyamoya disease.
    He S; Liang J; Xue G; Wang Y; Zhao Y; Liu Z; Hao X; Wei Y; Chen X; Wang H; Kang S; Wang R; Zhao Y; Ye X
    J Cereb Blood Flow Metab; 2023 Jul; 43(7):1194-1205. PubMed ID: 36883376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.